← board
XERS
distress 1/10 · well-funded / low risk$8.19-2%today-17% from 52w high
Revenue
$83M
Liquidity
$112M
Runway
—
Shares 1y
+7%
Price & events
+7.6% over 6M
CatalystRating changeDilutionFinancingdashed = today
-2.3%
1D
-5.8%
1W
+13.7%
1M
+37.6%
3M
+10.0%
6M
+59.9%
1Y
+222.2%
2Y
+143.6%
5Y
+54.1%
All
Overview
- Market Cap
- $1.41B
- Enterprise Value
- $1.52B
- Volume
- 150.19K
- 52 Week Range
- $5.00 – $9.90
- Total Shares
- 172.64M
- Float Shares
- 166.58M
- Short %
- 7.65%
- % Held by Insiders
- 3.38%
- % Held by Institutions
- 62.61%
- RVOL
- 0.07x
- Beta
- 0.85
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-06Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (2)
- GVOKE KITGLUCAGON2019 · Prescription
- KEVEYISDICHLORPHENAMIDE1958 · Prescription
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $11 (+38% upside) · 7 analysts
- 2026-03-02HC Wainwright & Co.Buy
- 2026-01-09HC Wainwright & Co.Buy
- 2025-12-09BarclaysOverweight
- 2025-11-07OppenheimerOutperform
- 2025-11-07HC Wainwright & Co.Buy
- 2025-11-07Piper SandlerNeutral
Competitors
- none identified
Recent news
- 2026-07-23Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
- 2026-07-21Women under 40 get a history lesson from Gen Xers’ rush to buy Costco’s Esprit sweatshirts - Upworthy
- 2026-07-17Xeris Biopharma (Nasdaq: XERS) ends 8% 2028 notes via cash and stock - Stock Titan
- 2026-07-17Here's the average net worth of American Gen Xers (how do you compare?) - MSN
- 2026-07-16The 401(k) decision Gen Xers regret the most - MSN
- 2026-07-16QumulusAI Begins Trading on the Nasdaq Global Market Under Ticker Symbol “QMLS” - Business Wire
- 2026-07-158 Reasons No One Wants To Hire Gen Xers Anymore - AOL.com
- 2026-07-15TRISO-X Awarded Tennessee Grant to Support Expansion of Nuclear Fuel Campus - GlobeNewswire
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.